|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 |
| (11) | Number of the document | 3405212 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17702951.9 |
| Date of filing the European patent application | 2017-01-16 | |
| (97) | Date of publication of the European application | 2018-11-28 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2017/050229 |
| Date | 2017-01-16 |
| (87) | Number | WO 2017/125844 |
| Date | 2017-07-27 |
| (30) | Number | Date | Country code |
| 201662280636 P | 2016-01-19 | US | |
| 201662419190 P | 2016-11-08 | US |
| (72) |
BINDER, Joseph John, US
CHO, Helen Kim, US
COCKLE, Paul Jason, US
FALCONER, Derek John, US
GURU, Siradanahalli, US
JOOSS, Karin Ute, US
MARTINIC, Marianne Marcela Andrea, US
WILLS, Kenneth Nelson, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | CANCER VACCINES |
| CANCER VACCINES |